)
)
J. Molner Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from J. Molner AS
Access all reports
J. Molner AS is a pharmaceutical company based in Tallinn, Estonia, specializing in the development and provision of generic drugs, particularly sterile injectable and dermatology formulations. The company serves pharmaceutical markets in the United States, Canada, and Europe. In addition to drug development, J. Molner AS offers analytical chemistry services, European market release support, and ongoing stability solutions for its clients. The company is headquartered in Tallinn, Estonia, and its shares are listed on the Nasdaq Tallinn.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
MOLNR
Country
🇪🇪 Estonia